Inventor · disambiguated record
Qing Li
Also filed as: LI QING · LI QING YOU
23 granted patents·11 pending applications·167 citations·filing 1997–2022
95Inventor score
Files withSENOMYX INC9LI XIAODONG7SOUND BIOPHARMACEUTICALS CO LTD3BJ BIOSCIENCE INC2KONINKLIJKE PHILIPS NV2
Top patents by PatentIndex Score
34 records- 0197US7906627B2Chimeric human sweet-umami and umami-sweet taste receptorsSENOMYX INC·Filed 2006·Granted Mar 15, 2011·49 cites·27 claims
- 0296US8247184B2Assays using chimeric T1R polypeptides for identifying putative taste modulatory compoundsLI XIAODONG·Filed 2011·Granted Aug 21, 2012·21 cites·37 claims
- 0392US7883856B2Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulatorsSENOMYX INC·Filed 2007·Granted Feb 8, 2011·16 cites·33 claims
- 0491US7939671B2Compounds that inhibit (block) bitter taste in composition and use thereofSENOMYX INC·Filed 2008·Granted May 10, 2011·15 cites·38 claims
- 0590US8273542B2Human T2R receptors for acetaminophen, ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulatorsLI XIAODONG·Filed 2011·Granted Sep 25, 2012·11 cites·26 claims
- 0686US10611812B2Interleukin 15 fusion protein for tumor targeting therapyNUMAB BIOPHARMACEUTICALS HANGZHOU LTD·Filed 2016·Granted Apr 7, 2020·5 cites·16 claims
- 0786US7939276B2Assays which screen for compounds that modulate bitter taste of chlorogenic lactone compoundsSENOMYX INC·Filed 2006·Granted May 10, 2011·6 cites·18 claims
- 0884US8030008B2Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulatorsSENOMYX INC·Filed 2006·Granted Oct 4, 2011·8 cites·37 claims
- 0981US8318447B2Use of bitter taste receptor to screen for compounds that offset the bitter taste of chlorogenic lactone containing coffee compositionsLI XIAODONG·Filed 2011·Granted Nov 27, 2012·3 cites·18 claims
- 1080US7407765B2Human T2R receptors for acetaminophen ranitidine, strychnine and denatomium and related assays for identifying human bitter taste modulatorsSENOMYX INC·Filed 2006·Granted Aug 5, 2008·5 cites·30 claims
- 1176US7915003B2Human T2R receptors for ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulatorsSENOMYX INC·Filed 2008·Granted Mar 29, 2011·3 cites·27 claims
- 1273US8524464B2Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulatorsLI XIAODONG·Filed 2011·Granted Sep 3, 2013·2 cites·21 claims
- 1373US6399576B1Method of inhibiting apoptosisTOBISHI PHARMACEUTICAL CO·Filed 2000·Granted Jun 4, 2002·5 cites·3 claims
- 1468US10520502B2Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulatorsFIRMENICH INCORPORATED·Filed 2017·Granted Dec 31, 2019·0 cites·5 claims
- 1565US9170254B2Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulatorsSENOMYX INC·Filed 2014·Granted Oct 27, 2015·0 cites·6 claims
- 1665US6106830AMethods for the treatment of apoptosis-related diseases by batroxobinTOBISHI PHARMACEUTICAL CO·Filed 1997·Granted Aug 22, 2000·18 cites·6 claims
- 1764US2022332779A1Interleukin 15 fusion protein for tumor targeting therapyBJ BIOSCIENCE INC·Filed 2022·Application pending·0 cites
- 1863US11236140B2Interleukin 15 fusion protein for tumor targeting therapyBJ BIOSCIENCE INC·Filed 2020·Granted Feb 1, 2022·0 cites·7 claims
- 1963US9778258B2Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulatorsSENOMYX INC·Filed 2015·Granted Oct 3, 2017·0 cites·10 claims
- 2058US8715946B2Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulatorsLI XIAODONG·Filed 2011·Granted May 6, 2014·0 cites·13 claims
- 2155US2025144099A1Ink4 tumor suppressor proteins mediate resistance to cdk4/6 kinase inhibitorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 2254US2023183344A1T-cell bispecific binding proteinsMAGENTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2353US9610608B2Self-assembly patterning of organic molecules on a surfaceUT BATTELLE LLC·Filed 2013·Granted Apr 4, 2017·0 cites·14 claims
- 2453US2010063146A1Method for treating disorders related to complement activationMEDOF M EDWARD·Filed 2007·Application pending·0 cites
- 2552US2024400711A1Cd38 monoclonal antibody and application thereofSOUND BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2652US2013183252A1Compounds that inhibit (block) bitter taste in composition and methods of making sameLI XIAODONG·Filed 2012·Application pending·0 cites
- 2751US12503515B2Humanized 4-1BB monoclonal antibody and pharmaceutical composition thereofSOUND BIOPHARMACEUTICALS CO LTD·Filed 2020·Granted Dec 23, 2025·0 cites·10 claims
- 2851US10974976B2pH control method for UpA cellKONINKLIJKE PHILIPS NV·Filed 2015·Granted Apr 13, 2021·0 cites·19 claims
- 2951US8148544B2Compounds that inhibit (block) bitter taste in composition and methods of making sameLI XIAODONG·Filed 2011·Granted Apr 3, 2012·0 cites·9 claims
- 3050US2019224251A1Methods of differentiating stem cells into endodermMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 3145US2017189366A1Method for treating disorders related to complement activationUNIV CASE WESTERN RESERVE·Filed 2016·Application pending·0 cites
- 3243US2018044207A1Controlling regeneration of an electrode in unidirectional ph adjustment of waterKONINKLIJKE PHILIPS NV·Filed 2016·Application pending·0 cites
- 3340US2022213216A1Bispecific antibody with double her2 sites for tumor immunotherapySOUND BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 3435US2018022734A1Sunitinib prodrug and pharmaceutical compositionSOUND BIOPHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qing Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →